Primary Care Can Help Restore US Antibiotic Stewardship, Starting with Flu Shots
Preventing viral infections with vaccination can keep the most vulnerable out of the hospital, reducing the risk of bacterial superinfections.
COVID-19 Update: US Vaccinations, Booster Doses, & Global Data as of August 29, 2022
Data from the CDC on US vaccination and booster shot rates and from the Johns Hopkins COVID-19 interactive map on cases and deaths in the US and worldwide.
Primary Viewpoints Episode 18: Why Humor Can be the Best Medicine for Clinicians
"Primary Viewpoints," a podcast from Patient Care Online, brings you an exclusive interview with Ernest R. Gelb, DO, 126th president of the American Osteopathic Association.
Superinfection Rate in Hospitalized COVID-19 Patients was Found to be Low
Only 9% of inpatients with COVID-19 had a bacterial superinfection that could be treated with antibiotics which curbed use of broad-spectrum antimicrobials.
COVID-19 Update: US Vaccinations, Booster Doses, & Global Data as of August 26, 2022
Pfizer Reports Positive Topline Phase 3 Data for Bivalent RSV Vaccine in Older Adults
Pfizer announced that a single dose of the vaccine, RSVpreF, demonstrated 85.7% efficacy against severe disease, defined by ≥3 symptoms.
Antimicrobial Resistance During COVID-19 Gained New Ground: Expert Perspective
Widespread antibiotic prescribing in the first year of the pandemic set back US progress on the fight against antimicrobial resistance, says Anne Meneghetti, MD.
Study Analyzing Efficacy of Nonhormonal Contraceptive Gel, Phexxi, for Prevention of Chlamydia, Gonorrhea Completes Last Subject Last Visit
Top-line data from the EVOGUARD clinical trial examining the efficacy of Phexxi for the prevention of chlamydia and gonorrhea are expected in October 2022.
COVID-19 Update: US Vaccinations, Booster Doses, & Global Data as of August 25, 2022
Novel Rapid-acting Treatment for Major Depressive Disorder First to Get FDA Nod
The dextromethorphan HBr-bupropion HCI combination uses the first new oral MOA in 6 decades and is labeled to improve depressive symptoms starting at 1 week.
Diagnoses of Youth-onset Type 2 Diabetes Spiked by 77% During First Year of COVID-19
Youth newly diagnosed with T2D also were metabolically sicker, with higher HbA1c, serum glucose levels, and BMI at presentation.
Three Flu Season Imperatives: Vaccinate the Young, the Old, and Everyone in Between
Influenza season in the southern hemisphere is "substantial," says Dr William Schaffner. To prepare: "Vaccinate, vaccinate, vaccinate!"
COVID-19 Update: US Vaccinations, Booster Doses, & Global Data as of August 24, 2022
Nonpharmacologic Treatments for Fibromyalgia: What Works for Which Symptoms?
Is acupuncture effective in reducing pain? Can exercise help patients with fibromyalgia sleep better? New systematic review and meta-analysis provides insight.
USPSTF Updated Guidance on Statin Use in Primary CVD Prevention Similar to 2016 Recommendations
The recommendations guide initiation of statin therapy in persons aged ≥40 years without a history of CVD and no current signs/symptoms of CVD.
COVID-19, Flu, or Both—There are Always Patients on the Fence
The patients on the vaccine fence are the ones that take the extra time and, over time, an added measure of patience for the clinician.
Moderna Requests Emergency Use Authorization for COVID-19 Bivalent Vaccine
Moderna filed with the FDA for emergency use authorization of a 50-µg dose of a BA.4./BA.5 Omicron-targeting bivalent booster vaccine for those aged ≥18 years.
COVID-19 Update: US Vaccinations, Booster Doses, & Global Data as of August 23, 2022
New Novo Nordisk Combination Rx Better than Components for T2D, Weight Loss
Phase II clinical trial shows a fixed dose combination of semaglutide/cagrilintide reduces HbA1c and weight much better than either drug alone.
Vegetarian Diet May Up Risk for Hip Fracture in Women
Among more than 26 000 women, a vegetarian diet was associated with a 33% greater risk of hip fracture vs diets that included fish or meat.
